Helen Parfrey - Concepedia

Author

Helen Parfrey

Also Known As

D. Parekh, E Oballa, Eunice Oballa, G. Ogg, H Baxendale, H Parfrey, H. Parfrey, Helen Parfrey, Justin M Oldham, K. Paques

144

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Papworth Hospital University of Cambridge Imperial College London University of Nottingham University of Edinburgh

About

Helen Parfrey is an author at Papworth Hospital specializing in medicine, pulmonary fibrosis, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	2K
2	Engineering	1	1	15
3	Health Sciences	1	1	377
4	Natural Sciences	1	1	59
5	Public Health	1	1	12

Helen Parfrey

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Taryn Reddy, Masaki Tominaga, David M. Hansell, European Respiratory Journal Recurrent InfectionsFibrosisUpper LobeMedical ImagingPleuroparenchymal Fibroelastosis	2012	377
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham, American Journal of Respiratory and Critical Care Medicine	2019	323
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study Richard J. Allen, Joanne Porte, Rebecca Braybrooke, The Lancet Respiratory Medicine	2017	294
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study Toby M. Maher, Eunice Oballa, Juliet K. Simpson, The Lancet Respiratory Medicine InflammationFibrosisIdiopathic Pulmonary FibrosisPulmonary Alveolar ProteinosisBiomarkers	2017	262
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial Toby M. Maher, Veronica A Tudor, Peter Saunders, The Lancet Respiratory Medicine	2022	245

Page 1